Evidence map›Paper›PMID 35119655›Full record

ArticleClinical journal of gastroenterology2022

Correction to: Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM‑free AIM.

Tomo Shimizu, Takashi Sawada, Tomohide Asai, Yuka Kanetsuki, Jiro Hirota, Michihisa Moriguchi, Tomoaki Nakajima, Toru Miyazaki, Takeshi Okanoue

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Tomo ShimizuTsukuba Research Institute Research and Development Division, Sekisui Medical Co., Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki, 301-0852, Japan. tomo_shimizu@sekisui.com.
Takashi SawadaTsukuba Research Institute Research and Development Division, Sekisui Medical Co., Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki, 301-0852, Japan.
Tomohide AsaiTsukuba Research Institute Research and Development Division, Sekisui Medical Co., Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki, 301-0852, Japan.
Yuka KanetsukiTsukuba Research Institute Research and Development Division, Sekisui Medical Co., Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki, 301-0852, Japan.
Jiro HirotaTsukuba Research Institute Research and Development Division, Sekisui Medical Co., Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki, 301-0852, Japan.
Michihisa MoriguchiDepartment of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Tomoaki NakajimaDepartment of Hepatology, Sapporo Kosei General Hospital, Hokkaido, 060-0033, Japan.
Toru MiyazakiLaboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan.
Takeshi OkanoueDepartment of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, 564-0013, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35119655
PMCPMC8858273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.